Cargando…
Oral manifestations in SARS-CoV-2 infection
BACKGROUND: We aimed to evaluate the prevalence of predisposing factors and oral manifestations in SARS-CoV-2 infection. MATERIAL AND METHODS: 204 SARS-CoV-2 positive patients were included in the study. Questions regarding the systemic, periodontal health, oral hygiene habits, common symptoms and,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medicina Oral S.L.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271340/ https://www.ncbi.nlm.nih.gov/pubmed/35717616 http://dx.doi.org/10.4317/medoral.25259 |
_version_ | 1784744657969741824 |
---|---|
author | Tuter, Gulay Yerebakan, Mukaddes Celik, Bulent Kara, Gulsah |
author_facet | Tuter, Gulay Yerebakan, Mukaddes Celik, Bulent Kara, Gulsah |
author_sort | Tuter, Gulay |
collection | PubMed |
description | BACKGROUND: We aimed to evaluate the prevalence of predisposing factors and oral manifestations in SARS-CoV-2 infection. MATERIAL AND METHODS: 204 SARS-CoV-2 positive patients were included in the study. Questions regarding the systemic, periodontal health, oral hygiene habits, common symptoms and, oral manifestations of COVID-19 such as oral lesions, and dry mouth were included in the survey. The Visual Analogue Scale (VAS) was used. RESULTS: 47.5% of individuals had various systemic diseases. Dry mouth (44.2%) and oral lesions (22.4%) were the most common oral manifestations in COVID-19 patients. Also, dry mouth had the highest VAS score. The most common oral lesion locations were buccal mucosa (15.2%) and tongue (10.8%). The majority of participants (142 patients) were affected by taste disorders. Patients who received periodontal treatment before SARS-CoV-2 infection reported fewer oral complaint and manifestations than those who did not receive periodontal therapy (p=0.032). There was no statistically significant difference between males and females on the presence of any oral manifestations, and taste disorders. CONCLUSIONS: Our results showed that SARS-CoV-2 could cause oral manifestations. However various predisposing factors may be part of the etiology and promote oral findings. Key words:SARS-CoV-2, COVID-19, xrestomia, dysgeusia, oral manifestation. |
format | Online Article Text |
id | pubmed-9271340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Medicina Oral S.L. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92713402022-07-11 Oral manifestations in SARS-CoV-2 infection Tuter, Gulay Yerebakan, Mukaddes Celik, Bulent Kara, Gulsah Med Oral Patol Oral Cir Bucal Research BACKGROUND: We aimed to evaluate the prevalence of predisposing factors and oral manifestations in SARS-CoV-2 infection. MATERIAL AND METHODS: 204 SARS-CoV-2 positive patients were included in the study. Questions regarding the systemic, periodontal health, oral hygiene habits, common symptoms and, oral manifestations of COVID-19 such as oral lesions, and dry mouth were included in the survey. The Visual Analogue Scale (VAS) was used. RESULTS: 47.5% of individuals had various systemic diseases. Dry mouth (44.2%) and oral lesions (22.4%) were the most common oral manifestations in COVID-19 patients. Also, dry mouth had the highest VAS score. The most common oral lesion locations were buccal mucosa (15.2%) and tongue (10.8%). The majority of participants (142 patients) were affected by taste disorders. Patients who received periodontal treatment before SARS-CoV-2 infection reported fewer oral complaint and manifestations than those who did not receive periodontal therapy (p=0.032). There was no statistically significant difference between males and females on the presence of any oral manifestations, and taste disorders. CONCLUSIONS: Our results showed that SARS-CoV-2 could cause oral manifestations. However various predisposing factors may be part of the etiology and promote oral findings. Key words:SARS-CoV-2, COVID-19, xrestomia, dysgeusia, oral manifestation. Medicina Oral S.L. 2022-07 2022-06-19 /pmc/articles/PMC9271340/ /pubmed/35717616 http://dx.doi.org/10.4317/medoral.25259 Text en Copyright: © 2022 Medicina Oral S.L. https://creativecommons.org/licenses/by/2.5/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Tuter, Gulay Yerebakan, Mukaddes Celik, Bulent Kara, Gulsah Oral manifestations in SARS-CoV-2 infection |
title | Oral manifestations in SARS-CoV-2 infection |
title_full | Oral manifestations in SARS-CoV-2 infection |
title_fullStr | Oral manifestations in SARS-CoV-2 infection |
title_full_unstemmed | Oral manifestations in SARS-CoV-2 infection |
title_short | Oral manifestations in SARS-CoV-2 infection |
title_sort | oral manifestations in sars-cov-2 infection |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271340/ https://www.ncbi.nlm.nih.gov/pubmed/35717616 http://dx.doi.org/10.4317/medoral.25259 |
work_keys_str_mv | AT tutergulay oralmanifestationsinsarscov2infection AT yerebakanmukaddes oralmanifestationsinsarscov2infection AT celikbulent oralmanifestationsinsarscov2infection AT karagulsah oralmanifestationsinsarscov2infection |